Incannex Healthcare Limited IHL.AX Stock
Incannex Healthcare Limited Price Chart
Incannex Healthcare Limited IHL.AX Financial and Trading Overview
Incannex Healthcare Limited stock price | 0.04 AUD |
Previous Close | 0.05 AUD |
Open | 0.05 AUD |
Bid | 0.04 AUD x 0 |
Ask | 0.04 AUD x 0 |
Day's Range | 0.04 - 0.05 AUD |
52 Week Range | 0.04 - 0.28 AUD |
Volume | 61.36M AUD |
Avg. Volume | 6.43M AUD |
Market Cap | 65.07M AUD |
Beta (5Y Monthly) | 2.088 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 AUD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
IHL.AX Valuation Measures
Enterprise Value | 32.3M AUD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 64.176704 |
Price/Book (mrq) | 0.77358496 |
Enterprise Value/Revenue | 31.855 |
Enterprise Value/EBITDA | -1.827 |
Trading Information
Incannex Healthcare Limited Stock Price History
Beta (5Y Monthly) | 2.088 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 0.28 AUD |
52 Week Low | 0.04 AUD |
50-Day Moving Average | 0.06 AUD |
200-Day Moving Average | 0.1 AUD |
IHL.AX Share Statistics
Avg. Volume (3 month) | 6.43M AUD |
Avg. Daily Volume (10-Days) | 13.88M AUD |
Shares Outstanding | 1.59B |
Float | 1.22B |
Short Ratio | N/A |
% Held by Insiders | 26.55% |
% Held by Institutions | 7.47% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2023 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | June 30, 2024 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -895.76% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -17.50% |
Return on Equity (ttm) | -33.30% |
Income Statement
Revenue (ttm) | 1.01M AUD |
Revenue Per Share (ttm) | 0.001 AUD |
Quarterly Revenue Growth (yoy) | 29.59% |
Gross Profit (ttm) | 1.01M AUD |
EBITDA | -17677036 AUD |
Net Income Avi to Common (ttm) | -19979558 AUD |
Diluted EPS (ttm) | -1.3 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 33.36M AUD |
Total Cash Per Share (mrq) | 0.02 AUD |
Total Debt (mrq) | 786.74K AUD |
Total Debt/Equity (mrq) | 0.94 AUD |
Current Ratio (mrq) | 9.019 |
Book Value Per Share (mrq) | 0.053 |
Cash Flow Statement
Operating Cash Flow (ttm) | -15942825 AUD |
Levered Free Cash Flow (ttm) | -7502621 AUD |
Profile of Incannex Healthcare Limited
Country | Australia |
State | VIC |
City | Docklands |
Address | 401 Docklands Drive |
ZIP | 3008 |
Phone | N/A |
Website | https://www.incannex.com.au |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Incannex Healthcare Limited, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. The company offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. It also develops IHL-42X, which has completed Phase IIb clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 skin that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury and concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, suppoCan gastro for IBD, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Docklands, Australia.
Q&A For Incannex Healthcare Limited Stock
What is a current IHL.AX stock price?
Incannex Healthcare Limited IHL.AX stock price today per share is 0.04 AUD.
How to purchase Incannex Healthcare Limited stock?
You can buy IHL.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Incannex Healthcare Limited?
The stock symbol or ticker of Incannex Healthcare Limited is IHL.AX.
Which industry does the Incannex Healthcare Limited company belong to?
The Incannex Healthcare Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Incannex Healthcare Limited have in circulation?
The max supply of Incannex Healthcare Limited shares is 1.59B.
What is Incannex Healthcare Limited Price to Earnings Ratio (PE Ratio)?
Incannex Healthcare Limited PE Ratio is 0.00000000 now.
What was Incannex Healthcare Limited earnings per share over the trailing 12 months (TTM)?
Incannex Healthcare Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Incannex Healthcare Limited company belong to?
The Incannex Healthcare Limited sector is Healthcare.
Incannex Healthcare Limited IHL.AX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P/ASX SMALL ORDINARIES AXSO | 3055.7 AUD 2022.44 USD |
-0.94
|
— — | 3042.1 AUD 2013.44 USD | 3084.6 AUD 2041.56 USD | — - | — — |
S&P/ASX 300 AXKO | 7711.3 AUD 5103.78 USD |
-0.4
|
— — | 7688.2 AUD 5088.49 USD | 7743.1 AUD 5124.83 USD | — - | — — |
- {{ link.label }} {{link}}